Natural products of plant origin as anticancer agents

Drug News and Perspectives

Volumn 14, Issue 8, 2001, Pages 465-482

  Ram, Vishnu Ji ^a   Kumari, Seema ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2'' DEOXY 2'' (DIMETHYLAMINO)ETOPOSIDE; ANNONA BULLATA EXTRACT; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; ASIMINA TRILOBA EXTRACT; BIOCHEMICAL MARKER; CAMPTOTHECIN; CARCINOGEN; CATHARANTHUS ROSEUS EXTRACT; CEPHALOTAXUS HARRINGTONIA EXTRACT; DATELLIPTIUM CHLORIDE; DOCETAXEL; ELEMENE; ETOPOFOS; EXATECAN; FLAVOPIRIDOL; HOMOHARRINGTONINE; IRINOTECAN; NAVELBINE; ONCHROSIA ELLIPTICA EXTRACT; PACLITAXEL; PLANT EXTRACT; TAXUS BREVIFOLIA EXTRACT; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINLEUROSINE; VISCUM ALBUM EXTRACT;

ADENOMA; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CARCINOMA; DIET; DRUG EFFICACY; DRUG MECHANISM; HUMAN; REVIEW; SARCOMA; ZEDOARY;

EID: 0035707873     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2001.14.8.858416     Document Type: Review

References (156)

1. Plants used against cancer - A survey
2. Nouvelles applications des poisons caryoclasiques à la pathologic experimenlale, à l'endocrindogie et à la cancerologie
3. Natural products in drug discovery and development
4. Historical development and potential uses of tumor antigens as markers of human cancer growth
5. Carcinofetal proteins II. Biochemical comparison of alpha-fetoprotein from human fetuses and patients with hepatocellular cancer
6. Use of a radio immuno assay for alphafetoprotein in the diagnosis of malignancy
7. Immunologic diagnosis and prognosis of human digestive tract cancer: Carcinoembryonic antigens
8. Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer
9. Ectopic ACTH production in carcinoma of the lung
10. Human calcitonin: Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma
11. Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract
12. Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen
13. A population screening for fetal sulfoglycoprotein antigen in gastric juice
14. Serum histaminase and calcitonin levels in medullary carcinoma of thyroid
15. Elevated histaminase (diamine oxidase) activity in small cell carcinoma of the lung
16. Glycosyltransferase and glycosidase activities in ovarian cancer patients
17. The Vinca alkaloids
18. Correlation of cytotoxicity and mitotic spindle dissolution by vinblastine in mammalian cells
19. Microtubule-associated protein MAP2 shares a microtubule binding motif with tau protein
20. Inhibition of protein kinase by antineoplastic agents: Implications for drug resistance
21. The role of vincristine in the treatment of childhood acute leukemia
22. Cis-Diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer
23. Neurotoxicity of common used antineoplastic agents
24. Immunufluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonus microtubules
25. Vinorelbine as a first line chemotherapy for metastatic breast carcinoma
26. Non-intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II
27. Role of topoisomerase 11 in mediating epipodophyllotixin-induced DNA cleavage
28. Inhibition of epipodophlyllotoxin cytotoxicty by interference with topoisomerase-mediated DNA cleavage
29. Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents
30. Peroxidative free radical formation and 0-demethylation of etoposide (VP-16) and teniposide (VM-26)
31. Etoposide (VP-16-213): Current status of an active anticancer drug
32. Treatment of epidemic Kaposi's sarcoma with VP-16-213 (etoposide) and combination of doxorubicin, bleomycin and vinblastine (ABV)
33. Antitumor agents 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4′-demethyl epipodophyllotoxin as potent inhibitors of human DNA topoisomerase II
34. Antitumor agents. 113. New 4beta-arylamino derivatives of 4′-0-demethyl epipodophyllotoxin and related compound as potent inhibitor of human DNA topoisomerase II
35. Etoposide phosphate disodium salt: Anti-neoplastic
36. NK-611. Antineoplastic podophyllotoxin derivative
37. Top-53. Antineoplastic podophyllotoxin DNA topoisomerase II inhibitor
38. Promotion of microtubule assembly in vitro by taxol
39. Taxol stabilizes microtubules in mouse fibroblast cells
40. Taxol: An antimitotic agent with a new mechanism of action
41. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol
42. Taxol binds to polymerized tubulin in vitro
43. Taxol: A novel radiation sensitizer
44. Phase I trial taxol given as a 3-hour infusion every 21 days
45. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
46. Relationship between the structure of taxol analogues and their antimitotic activity
47. Modified taxols. SI. Reaction of taxol with electrophilic reagents and preparation of a rearranged taxol derivative with tubulin assembly activity
48. Biochemical basis for interactions of type I and type II topoisomerases with DNA
49. Camptothecin-induced protein-linked DNA breaks via mammalian DNA topoisomerase I
50. Identification of mammalian DNA topoisomerase I as an intercellular target of the anticancer drug camptothecin
51. New technique for coupling the cleavage and religation reactions of eukaryotic topoisomerase 1. The mode of action of camptothecin at a specific recognition site
52. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase 1
53. Camptothecin cytotoxity in mammalian cell is associated with the induction of persistent double-strand breaks in replicating DNA
54. Supercoiling of the DNA template during RNA transcription
55. Topotecan hydrochloride. Antineoplastic, topoisomerase I inhibitor
56. 9-Aminocamptothecin antineoplastic, DNA topoisomerase I inhibitor
57. Synthesis and antitumor activity of novel water-soluble derivatives of camptothecin as specific inhibitor of topoisomerase I
58. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogs
59. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo
60. Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay
61. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment
62. Studies on the mechanism of inhibition of harringtonine on DNA biosynthesis II. Effect of harringtonine on DNA polymerase alpha
63. Inhibition of translation in eukaryotic systems by harringtonine
64. Synthesis of harringtonine, a cephalotaxus antitumor alkaloid
65. Preparation of horringtonine from cephalotoxine
66. Synthesis of isoharringtonine
67. Separation and determination of isoharringtonine and its stereoisomers
68. Synthesis of deoxyharringtonine
69. A study on deoxyharringtonine and its analogs
70. Synthesis of cephalotaxus ester alkaloids
71. Separation of the two epimers of three cephalotaxus ester alkaloids by thin-layer chromatography
72. Plants used against cancer, a survey
73. Isolation and properties of the three lectins from mistletoe (Viscum album)
74. Isolation and characterisation of viscumin toxic lectin from Viscum album. I. (Mistletoe)
75. Mistletoe lectins and their A and B chains
76. Photochemical and pharmacological study of Viscum album. I. Viscotoxin. Its isolation and properties
77. The alkaloid contents of a parasitic plant living on Dubosia myoporoides
78. Isolation of biologically active alkaloids from Korean mistletoe Viscum album coloratum
79. The A chain of lectin 1 from European mistletoe (Viscum album) induces interleukin-1 and interleukin-2 in human mononuclear cells
80. Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapy
81. Effect of a preparation of Viscum album on tumor reduction in experimental animals
82. Viscum album - A possible treatment for cancer
83. Prophylactic treatment against recurrence in cases of operated carcinoma of the branchial tree with mistletoe preparation, Iscador
84. The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats
85. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L1210 leukemia
86. Preparation of low-density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P388 leukemic cells in vitro
87. Conjugates of elliptinium acetate with mouse monoclonal anti-alpha-fetoprotein antibodies or Fab fragments: In vitro cytotoxic effects upon human hepatoma cell lines
88. Rational design of a novel ellipticine derivative with significant activity against human lung cancer cell lines
89. 1-Fanctionalized 5,6-dimethyl-6H-pyrido[4,3-b]carbazoles (ellipticines) and analogues: A new rapid synthesis
90. Phase II study of elliptinium in advanced breast cancer
91. Phase I trial of elliptinium acetate in advanced renal cell carcinoma
92. Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma
93. Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung
94. Echic de l'acetate d'elliptinium dans le traitment de l' hepatocarcinome inoperable (essai phase II)
95. Essai randomise de lacetate d'elliptinium et du tamaxlfene dans le traitment des carcinomes hepatocellulaires inoperables
96. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase 11
97. Bullatacin and bullatacinone: Two highly potent bioactive acetogenine from Annona bullata
98. Bullatalicin, a novel, bioactive acetogenin from Annona bullata (Annonaceae)
99. Human medicinal agents from plants
100. 30, 31-and 32-Hydroxybullatacinones: Bioactive terminally hydroxylated annonaceous acetogenins from Annona bullata
101. Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin from the bark of Asimina triloba
102. Asimilobin and cis-and trans-murisolinones, novel bioactive annonaceous acetogenins from the seeds of Asimina triloba
103. Uvaricin, a new antitumor agent from Uvaria accuminata (Annonaceae)
104. Asimicin, a new cytotoxic and pesticidal acetogenin from the paw, Asimina triloba (Annonaceae)
105. Mode of action of bullatacin: A potent antitumor and pesticidal annonaceous acetogenin
106. Mode of action of bullatacin, a potent antitumor acetogenin: Inhibition of NADH oxidase activity of HELA and HL-60, but not liver plasma membranes
107. Isolation and determination of elemene
108. Pharmacological studies on antitumor activities of beta-elemene
109. Synergism in the cytotoxic effect of beta-elemene combined with adriamycin or cisplatin on human gastroadenocarcinoma
110. Pharmacology and clinical studies of elemene, a new anticancer agent
111. The antitumor activities of elemene are associated with apoptosis
112. Apoptosis - The key to future anticancer therapy
113. Several new targets of antitumor agents
114. Effect of elemene on serum superoxide dismutase activity in patients with brain tumors
115. Effect of elemenum emulsion on peripheral blood T lymphocyte subsets in patients with various tumors
116. Phase II clinical trials of elemene in the treatment of advanced malignant tumors
117. Phase III clinical trials of elemene emulsion in the management of malignant pleural and peritoneal effusions
118. Chemoprevention of cancer
119. Inhibition of carcinogenesis by minor dietary constituents
120. Status of research on nutrition and cancer: Concluding remarks
121. Dietary factors and special epidemiological situation of liver cancer in Thailand and Africa
122. Intake of fried meat and risk of cancer: A follow-up study in Finland
123. Retinoids as chemopreventive and therapeutic agents
124. Curcumin: Chemopreventive
125. Tea and chemoprevention of cancer
126. Organo selenium compounds: A novel class of cancer chemopreventive agents
127. Cyclins and cancer
128. Cyclins and cancer II: Cyclin D and Cdk inhibitors come of age
129. Cyclins and oncogenesis
130. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
131. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
132. Cancer immunotherapy using DNA vaccination
133. The antitumor potential of interleukin-12
134. Chemosensitizers in tumor therapy: New compounds promise better efficacy
135. Development of multidrug resistance protein inhibitors
136. A K-2123: Radiosensitizer